Emma Walmsley, GSK CEO (Xavier Collin/Image Press Agency/Sipa USA/Sipa via AP Images)
GSK still riding vaccine sales wave, pushing 2024 forecasts higher
GSK’s vaccines portfolio is front and center as it kicks off 2024.
The UK pharma said its non-Covid vaccine sales grew 22% in the first …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
